DrugPatentWatch Database Preview
Watson Labs Company Profile
What is the competitive landscape for WATSON LABS, and what generic and branded alternatives to WATSON LABS drugs are available?
WATSON LABS has one thousand one hundred and twelve approved drugs.
There are twenty-three tentative approvals on WATSON LABS drugs.
Summary for Watson Labs
| US Patents: | 0 |
| Tradenames: | 416 |
| Ingredients: | 386 |
| NDAs: | 1112 |
Drugs and US Patents for Watson Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | MAPROTILINE HYDROCHLORIDE | maprotiline hydrochloride | TABLET;ORAL | 071944-001 | Dec 30, 1987 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Watson Labs | PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; propranolol hydrochloride | TABLET;ORAL | 070305-001 | Apr 18, 1986 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Watson Labs | PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride; perphenazine | TABLET;ORAL | 073008-001 | Oct 17, 1991 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Watson Labs | NAPROXEN SODIUM | naproxen sodium | TABLET;ORAL | 074195-001 | Dec 21, 1993 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
